Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

16 results
Display

Dose and Treatment Duration of Regimen

Kweon YO

  • KMID: 760573
  • Korean J Hepatol.
  • 2005 Mar;11(1):13-16.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Indication of Drug Therapy in Patients with Chronic Hepatitis B

Cho M

  • KMID: 760571
  • Korean J Hepatol.
  • 2005 Mar;11(1):1-8.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Inflammatory Pseudotumor of the Liver

Jin SY

  • KMID: 760585
  • Korean J Hepatol.
  • 2005 Mar;11(1):90-93.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Monitoring Patients with Chronic HBV Infection During Antiviral Therapy

Kim YS

  • KMID: 760572
  • Korean J Hepatol.
  • 2005 Mar;11(1):9-12.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Efficacy of Lamivudine in Korean Patients with Chronic Hepatitis B

Choi JY

  • KMID: 760576
  • Korean J Hepatol.
  • 2005 Mar;11(1):25-30.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prophylaxis Against Hepatitis B Recurrence Following Liver Transplantation

Suh KS

  • KMID: 760575
  • Korean J Hepatol.
  • 2005 Mar;11(1):21-24.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Efficacy of Alpha-Interferon in Korean Patiens with Chronic Hepatitis B

Koh KC

  • KMID: 760577
  • Korean J Hepatol.
  • 2005 Mar;11(1):31-33.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Completely Ablated Hepatocellular Carcinoma by Percutaneous Radiofrequency Thermal Ablation

Han JK, Kim SH

  • KMID: 760586
  • Korean J Hepatol.
  • 2005 Mar;11(1):94-96.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Antiviral Therapy in Hepatitis B Carriers Undergoing Immunosuppressive Treatment or Cytotoxic Chemotherapy

Yoon JH

  • KMID: 760574
  • Korean J Hepatol.
  • 2005 Mar;11(1):17-20.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Vanishing Bile Duct Syndrome Associated with Hypersensitivity to Allopurinol

Choi SH, Yang SH, Song YB, Kim HJ, Seo YT, Choi DS, Moon KH, Byun JH, Yu ES

  • KMID: 760583
  • Korean J Hepatol.
  • 2005 Mar;11(1):80-85.
Allopurinol is frequently used for the treatment of hyperuricemia and gout. Sometimes, a life-threatening reaction develops, as is illustrated by the following case report. We describe a 60-year-old male...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Primary Adenosquamous Carcinoma of the Liver: A Case Report

Gu MJ, Choi JH, Park WK, Chang JC, Kim HJ

  • KMID: 760584
  • Korean J Hepatol.
  • 2005 Mar;11(1):86-89.
Primary adenosquamous cell carcinoma of the liver, a variant of cholangiocarcinoma is very rare disease and its prognosis is known to be very poor. We describe here a case...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prostaglandin A2 Induces Caspase-independent Apoptosis in Hepatocellular Carcinoma Cells

Kim HS, Shim JC, Choi JY, Rhim H, Kim IK

  • KMID: 760582
  • Korean J Hepatol.
  • 2005 Mar;11(1):72-79.
BACKGROUND/AIMS: Prostaglandin (PG) A2 has been reported to inhibit the growth of hepatocellular carcinoma cells via activation of apoptosis, although the molecular mechanisms involved have not been clarified, yet....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Relationship between the Severity of Liver Damage and the Serum Leptin Level for Nonalcoholic Fatty Liver Disease

Kim KO, Park SH, Park CH, Han TH, Yoo KS, Kim JH, Lee MS, Kim DJ, Park CK, Cho HD

  • KMID: 760580
  • Korean J Hepatol.
  • 2005 Mar;11(1):51-58.
BACKGROUND/AIMS: Nonalcoholic fatty liver disease (NAFLD) represents a spectrum of conditions that are mainly characterized histologically by macrovesicular hepatic steatosis. There are two histologic patterns of NAFLD: simple steatosis...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Comparative Results of Radiofrequency Ablation versus Surgical Resection for the Treatment of Hepatocellular Carcinoma

Cho CM, Tak WY, Kweon YO, Kim SK, Choi YH, Hwang YJ, Kim YI

  • KMID: 760581
  • Korean J Hepatol.
  • 2005 Mar;11(1):59-71.
BACKGROUND/AIMS: Although surgical resection remains the gold standard of therapy for hepatocellular carcinoma (HCC), only selected patients can undergo resection because of the severity of the underlying cirrhosis or...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Prevalence and Clinical Characteristics of Hepatitis-delta Infection in Korea

Jeong SH, Kim JM, Ahn HJ, Park MJ, Paik KH, Choi W, Kim J, Han CJ, Kim YC, Lee JO, Hong YJ, Park HY, Jeong HH, Yoon MY, Lee M, Lee KH

  • KMID: 760579
  • Korean J Hepatol.
  • 2005 Mar;11(1):43-50.
BACKGROUND/AIMS: The prevalence of hepatitis delta virus (HDV) infection has been estimated as being approximately 5% among global HBsAg carriers. The anti-delta positive rate in Koreans had been reported...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
HBV-specific CD8+ T cells for Sustained HBeAg Seroconversion after Lamivudine Therapy

Lee CK, Han KH, Suh JH, Cho YS, Won SY, Chon CY, Moon YM, Park IS

  • KMID: 760578
  • Korean J Hepatol.
  • 2005 Mar;11(1):34-42.
BACKGROUND/AIMS: Viral suppression of the hepatitis B virus (HBV) can be induced by lamivudine, but the relapse seen in many patients after cessation of lamivudine therapy is troublesome. We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr